Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
12th Jul 20171:43 pmRNSDirector/PDMR shareholding and Total Voting Rights
30th Jun 20177:00 amRNSDirector/PDMR Shareholding
29th Jun 201712:06 pmRNSResult of AGM
29th Jun 20177:00 amRNSAGM Statement
19th Jun 20172:15 pmRNSHolding(s) in Company
7th Jun 20174:22 pmRNSHolding(s) in Company
5th Jun 201710:20 amRNSDividend date
26th May 20171:53 pmRNSNotice of AGM
23rd May 20173:31 pmRNSHolding(s) in Company
9th May 20175:21 pmRNSDirector/PDMR Shareholding
23rd Mar 20177:00 amRNSDirector Declaration
10th Mar 20177:00 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amBUSFinal Results
1st Mar 20178:39 amRNSHolding(s) in Company
23rd Feb 20177:00 amRNSReplacement Announcement
15th Feb 20174:29 pmRNSHolding(s) in Company
15th Feb 20172:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Feb 20177:00 amRNSAcquisition
2nd Feb 20177:00 amRNSTrading Statement
1st Dec 20167:00 amRNSTotal Voting Rights
22nd Nov 20167:00 amRNSEmployee Share Plan and Directors' Dealing
6th Oct 201611:46 amRNSHolding(s) in Company
16th Sep 20164:36 pmRNSDirector/PDMR Shareholding and Share Plan Limits
14th Sep 20167:30 amBUSHalf-year Report
9th Sep 20163:21 pmRNSTotal Voting Rights
4th Aug 20163:33 pmRNSTotal Voting Rights
4th Aug 20163:32 pmRNSBlock listing Interim Review
6th Jul 20165:00 pmRNSDirector/PDMR Shareholding
6th Jul 20167:00 amRNSHolding(s) in Company
4th Jul 20163:38 pmRNSTotal Voting Rights
29th Jun 20165:17 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
13th Jun 20167:00 amRNSTotal Voting Rights
21st Apr 201612:05 pmRNSHolding(s) in Company
8th Mar 20167:00 amBUSFinal Results
29th Feb 20164:59 pmRNSBlocklisting Interim Review
1st Feb 20167:00 amRNSTrading Statement
13th Jan 201611:00 amRNSBoard and Management Changes
3rd Dec 201511:19 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
21st Sep 20155:23 pmRNSDirector/PDMR Shareholding
16th Sep 20154:55 pmRNSDirector/PDMR Shareholding
16th Sep 20157:00 amBUSHalf-yearly Report
31st Jul 20153:40 pmRNSTotal Voting Rights
31st Jul 20153:39 pmRNSBlocklisting Interim Review
25th Jun 20151:21 pmRNSResult of AGM
25th Jun 20157:00 amRNSAGM Statement
2nd Jun 20152:49 pmRNSHolding(s) in Company
27th May 20158:38 amRNSDirector/PDMR Shareholding
22nd Apr 20151:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.